ClinicalTrials.gg
Drug

Rezpegaldesleukin clinical trials

Also written NKTR-358 and LY3471851.

studies test it
14
open now
3
in phase 3
2
first study started
2017

How each study uses rezpegaldesleukin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the rezpegaldesleukin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rezpegaldesleukin
6
REZPEG
3
LY3471851 (formerly)
2

Development codes

NKTR-358
13
LY3471851
9

Studies by the year they started

14 studies that test it; most in 2019 (3)

Studies that test rezpegaldesleukin, by start year
YearStudies
20171
20181
20193
20201
20212
20221
20231
20241
20263

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
5
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 1

Nektar Therapeutics (13) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Studies

Open first, then newest update. How each study uses rezpegaldesleukin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call rezpegaldesleukin · ClinicalTrials.gg INT018244

  • UNII (FDA) VGR86P26ERREZPEGALDESLEUKINOne source FDA
  • NCI Thesaurus C188643RezpegaldesleukinOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.